You must be logged in and own this session in order to
1/13/21 11:46 am
Good day sir.
This is now an emerging trend in search for Sarscov-2 Ab drugs- ensuring it's capacity for cross neutralization across emerging strains.
Then, not loosing sight of qualities for long lasting protection.
Testing mAb with support mAb in cocktails
version against Sarscov-2 is also emerging, to support efficacy, as reported from some studies.
Nice work sir.